Epilepsy Research
Volume 24, Issue 2 , Pages 91-100 , June 1996

Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents

Received 9 October 1995 ,Revised 2 January 1996 ,Accepted 9 January 1996.

References 

  1. Bagetta G, Ianonne M, Scorsa AM, Nistico G. Tacrine-induced seizures and brain damage in LiCl-treated rats can be prevented by Nω-nitro-l-arginine methyl ester. Eur. J. Pharmacol. 1992;213:301–304
  2. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: an endogenous anticonvulsant. NeuroReport. 1993;4:444–446
  3. Buxton ILO, Cheek DJ, Eckman D, Westfall DP, Sanders KM, Keef KD. NG-Nitro-l-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 1993;72:387–395
  4. Dawson VL, Dawson TL, London ED, Bredt DH, Snyder SH. Nitric oxide mediates glutamate toxicity in primary cortical cultures. In: 2nd Ed.. Proc. Natl. Acad. Sci. USA. 88:1991;p. 6368–6371
  5. De Sarro GB, Donato Di Paola E, De Sarro A, Vidal MJ. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fund. Clin. Pharmacol. 1991;5:503–511
  6. De Sarro GB, Donato Di Paola E, De Sarro A, Vidal MJ. l-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol. 1993;230:151–158
  7. Golden GT, Smith GG, Ferraro TN, Reyes PF, Kulp JK, Fariello RG. Strain differences in convulsive responses to the excitotoxin kainic acid. NeuroReport. 1991;2:141–144
  8. Grooms SY, Jones LS. Hippocampal in vitro kindling is not blocked by nitric oxide synthase inhibitors. NeuroReport. 1994;5:1102–1104
  9. Haberny KA, Pou S, Eccles CU. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett. 1992;146:187–190
  10. Herberg LH, Grottick A, Rose IC. Nitric oxide synthesis, epileptic seizures and kindling. Psychopharmacology. 1995;119:115–123
  11. Iadecola C, Bietz AJ, Renno W, Xu X, Mayer B, Zhang F. Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvessels. Brain Res. 1993;606:184
  12. Kelly PAT, Ritchie IM, Arbuthnitt GW. 7-Nitro indazole uncouples cerebral blood flow from metabolic demand in the conscious rat. Br. J. Pharmacol. 1994;112:348P
  13. Kirkby RD, Forbes RA, Subramaniam S. Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice. Epilepsy Res. 1996;24:79–90
  14. Manzoni O, Prezeau L, Deshager S, Sahuquet A, Sladeczek F, Bockaert JL, et al. Sodium nitroprusside blocks NMDA receptors via formation of ferrocyanide ions. NeuroReport. 1992;3:77–80
  15. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert JL, Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 1992;8:653–662
  16. Mollace V, Bagetta G, Nistico G. Evidence that l-arginine possesses proconvulsant effects mediated through nitric oxide. NeuroReport. 1991;2:269–272
  17. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 1991;108:296–297
  18. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 1993;110:219–224
  19. Mulsch A, Busse R, Mordvintcev PI, Vanin A, Nielsen EO, Scheel-Kruger J, et al. Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport. 1994;5:2325–2328
  20. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation. In: 2nd Ed.. Proc. Natl. Acad. Sci. USA. 88:1991;p. 11285–11289
  21. Osonoe K, Mori N, Suzuki K, Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 1994;663:338–340
  22. Penix LP, Davis W, Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res. 1994;18:177–184
  23. Przegalinski E, Baran L, Siwanowicz J. The role of nitric oxide in kainate-induced seizures in mice. Neurosci. Lett. 1994;170:74–76
  24. Rigaud-Monnet A-S, Pinard E, Borredon J, Seylaz J. Blockade of nitric oxide synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures. J. Cereb. Blood Flow Metab. 1994;14:581–590
  25. Rondouin G, Bockaert J, Lerner-Natoli M. l-Nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport. 1993;3:1187–1190
  26. Rondouin G, Lerner-Natoli M, Manzoni O, Lafon-Cazal M, Bockaert J. A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. NeuroReport. 1992;3:805–808
  27. Rundfeldt L, Koch R, Richter A, Meuissen M, Gerecke V, Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur. J. Pharmacol. 1995;274:73–81
  28. Starr MS, Starr BS. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav. 1993;45:321–325
  29. Wang Q, Theard MA, Pellegrino DA, Baughman VL, Hoffman WE, Albrecht RF, et al. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res. 1994;658:192–198

PII: 0920-1211(96)00005-8

Epilepsy Research
Volume 24, Issue 2 , Pages 91-100 , June 1996

Article Tools